Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

United States Hyperparathyroidism Market and Competitive Landscape Highlights Report 2010-2020 - Research and Markets

Research and Markets
Posted on: 05 Oct 16

Research and Markets has announced the addition of the "US Hyperparathyroidism Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

The latest research US Hyperparathyroidism Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Hyperparathyroidism pipeline products, Hyperparathyroidism epidemiology, Hyperparathyroidism market valuations and forecast, Hyperparathyroidism products sales and competitive landscape in the US.

US Hyperparathyroidism Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Hyperparathyroidism pipeline products, Hyperparathyroidism epidemiology, Hyperparathyroidism market valuations and forecast, Hyperparathyroidism products sales and competitive landscape in the US.

The research is classified into nine sections - Hyperparathyroidism overview including etiology, pathophysiology, and diagnosis, Hyperparathyroidism treatment options, Hyperparathyroidism pipeline products, Hyperparathyroidism market analysis comprising of Hyperparathyroidism epidemiology, key products marketed for Hyperparathyroidism, market valuations and forecast, products sales and market shares.

Research Scope:

  • Hyperparathyroidism Pipeline: Find out the products in clinical trials for the treatment of Hyperparathyroidism by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Hyperparathyroidism Epidemiology: Find out the number of patients diagnosed (prevalence) with Hyperparathyroidism in the US
  • Hyperparathyroidism Products: Identify key products marketed and prescribed for Hyperparathyroidism in the US, including trade name, molecule name, and company
  • Hyperparathyroidism Product Sales: Find out the sales revenues of Hyperparathyroidism products, both branded and generics, in the US
  • Hyperparathyroidism Market Valuations: Find out the market size for Hyperparathyroidism products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Hyperparathyroidism Products Market Share: Find out the market shares for key Hyperparathyroidism products in the US

Key Topics Covered:

  1. Disease Overview
  2. Hyperparathyroidism Treatments
  3. Hyperparathyroidism Pipeline
  4. US Hyperparathyroidism Epidemiology
  5. Marketed Drugs for Hyperparathyroidism in US
  6. US Hyperparathyroidism Market Size
  7. US Hyperparathyroidism Products Sales
  8. US Hyperparathyroidism Market Competitive Landscape
  9. US Hyperparathyroidism Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/jmggzg/us.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005005819/en/

Business Wire
www.businesswire.com

Last updated on: 05/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.